| 1 |
34734218 | Emerging investigator series: human CYP2A6 catalyzes the oxidation of 6:2 fluorotelomer alcohol. | 2021 Nov 17 |
2 |
| 2 |
24527722 | Electrochemical detection of human cytochrome P450 2A6 inhibition: a step toward reducing dependence on smoking. | 2014 Mar 4 |
2 |
| 3 |
22696418 | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 2012 Sep |
1 |
| 4 |
21418183 | Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. | 2011 Jul |
1 |
| 5 |
19702528 | Structure, function, regulation and polymorphism of human cytochrome P450 2A6. | 2009 Sep |
1 |
| 6 |
15980104 | Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans. | 2005 Sep |
1 |
| 7 |
11181487 | In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. | 2001 Mar |
2 |
| 8 |
11353760 | Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. | 2001 Jun |
7 |
| 9 |
10911933 | Mimicking gene defects to treat drug dependence. | 2000 |
1 |
| 10 |
10418968 | Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. | 1999 Jun 1 |
1 |
| 11 |
9143352 | Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. | 1997 May 1 |
4 |